These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30466077)

  • 21. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study.
    Lee BJ; Hsu CY; Parikh RV; Leong TK; Tan TC; Walia S; Liu KD; Hsu RK; Go AS
    BMC Nephrol; 2018 Jun; 19(1):134. PubMed ID: 29890946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients.
    Chiang CK; Ho TI; Hsu SP; Peng YS; Pai MF; Yang SY; Hung KY; Tsai TJ
    Blood Purif; 2005; 23(2):134-40. PubMed ID: 15665509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Kuwamura Y; Shoji T; Okute Y; Yamazaki Y; Motoyama K; Morioka T; Mori K; Fukumoto S; Tsujimoto Y; Shioi A; Emoto M; Inaba M
    J Ren Nutr; 2018 Jan; 28(1):54-63. PubMed ID: 29089279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients.
    Masuda T; Murata M; Honma S; Iwazu Y; Sasaki N; Ogura M; Onishi A; Ando Y; Muto S; Shimada K; Kario K; Kusano E; Asano Y
    Nephrol Dial Transplant; 2011 Jul; 26(7):2289-95. PubMed ID: 21220756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of multidisciplinary pre-dialysis education in advanced chronic kidney disease: Propensity score matched cohort analysis.
    Cho EJ; Park HC; Yoon HB; Ju KD; Kim H; Oh YK; Yang J; Hwang YH; Ahn C; Oh KH
    Nephrology (Carlton); 2012 Jul; 17(5):472-9. PubMed ID: 22435951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients.
    Lin FJ; Zhang X; Huang LS; Ji G; Huang HD; Xie Y; Jiang GR; Zhou X; Lu W
    Int Urol Nephrol; 2018 Sep; 50(9):1703-1712. PubMed ID: 29974406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of Excess Pressure Integral for Predicting 15-Year All-Cause and Cardiovascular Mortalities in End-Stage Renal Disease Patients.
    Huang JT; Cheng HM; Yu WC; Lin YP; Sung SH; Wang JJ; Wu CL; Chen CH
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.
    Maduell F; Varas J; Ramos R; Martin-Malo A; Pérez-Garcia R; Berdud I; Moreso F; Canaud B; Stuard S; Gauly A; Aljama P; Merello JI
    Am J Nephrol; 2017; 46(4):288-297. PubMed ID: 29041011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic role of brain natriuretic peptides in hemodialysis patients.
    Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
    Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.
    Chung CM; Lin MS; Chang CH; Cheng HW; Chang ST; Wang PC; Chang HY; Lin YS
    Atherosclerosis; 2017 Dec; 267():158-166. PubMed ID: 28985950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
    Airy M; Mandayam S; Mitani AA; Chang TI; Ding VY; Brookhart MA; Goldstein BA; Winkelmayer WC
    Nephrol Dial Transplant; 2015 Dec; 30(12):2068-75. PubMed ID: 26311216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients.
    Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kimura G
    Ren Fail; 2002 Mar; 24(2):175-86. PubMed ID: 12071591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
    Solomon SD; Anavekar N; Skali H; McMurray JJ; Swedberg K; Yusuf S; Granger CB; Michelson EL; Wang D; Pocock S; Pfeffer MA;
    Circulation; 2005 Dec; 112(24):3738-44. PubMed ID: 16330684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of low triiodothyronine levels on mortality is mediated by malnutrition and cardiac dysfunction in incident hemodialysis patients.
    Koo HM; Kim CH; Doh FM; Lee MJ; Kim EJ; Han JH; Han JS; Oh HJ; Han SH; Yoo TH; Kang SW
    Eur J Endocrinol; 2013 Oct; 169(4):409-19. PubMed ID: 23857979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction.
    Ganda A; Weiner SD; Chudasama NL; Valeri AM; Jadoon A; Shimbo D; Radhakrishnan J
    Clin Nephrol; 2012 May; 77(5):366-75. PubMed ID: 22551882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease.
    Chen SC; Chang JM; Liu WC; Huang JC; Tsai JC; Lin MY; Su HM; Hwang SJ; Chen HC
    Nephrol Dial Transplant; 2012 Mar; 27(3):1064-70. PubMed ID: 21813825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysis vintage and cardiovascular injury as factors influencing long-term survival in peritoneal dialysis and hemodialysis.
    Hoppe K; Schwermer K; Olewicz-Gawlik A; Klysz P; Kawka A; Baum E; Sikorska D; Ścigacz K; Roszak M; Lindholm B; Pawlaczyk K; Oko A
    Adv Clin Exp Med; 2017; 26(2):251-258. PubMed ID: 28791842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.